pharmaceuticals for the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals for the treatment of life-threatening diseases; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics for use in the treatment of neurodegenerative disorders, amyotrophic lateral sclerosis (ALS), dementia, cancer, Parkinson's Disease, and obesity; pharmaceuticals, namely, ribonucleic acid (RNA) therapeutics that feature RNA as their active ingredient; pharmaceuticals, namely, small molecule therapeutics that induce changes in the chemical modifications of ribonucleic acid (RNA)

'acid':31,37,62,86 'activ':70 'al':11,51 'amyotroph':8,48 'cancer':13,53 'chang':79 'chemic':82 'dementia':12,52 'diseas':16,27,56 'disord':7,47 'featur':66 'induc':78 'ingredi':71 'later':9,49 'life':25 'life-threaten':24 'modif':83 'molecul':75 'name':29,35,60,73 'neurodegen':6,46 'obes':18,58 'parkinson':14,54 'pharmaceut':1,19,28,34,59,72 'ribonucl':30,36,61,85 'rna':32,38,63,67,87 'sclerosi':10,50 'small':74 'therapeut':33,39,64,76 'threaten':26 'treatment':4,22,44 'use':41

TINOS THERAPEUTICS

Owners

Goods & Services